Dramatist pleased her most enduring play gets Canadian première at PTE

Kate was in the Winnipeg Free Press in November and my Google Alerts just picked it up :/ On well, better late than never.

The first and last time Kate Hewlett came to town with a play was in 2003, as a newly graduated theatre student making her fringe festival debut in the dance/musical drama On the Body.

"It was a disaster -- we got one star," says Hewlett, recalling her Free Press review. "We were proud of the show but it just got slammed and no one came. It was a very disappointing time. You can say that physical theatre show is what got me writing."
[Read More]
david hewlett sl 08

State of Syn

Shaftesbury and Smokebomb to launch new original science fiction digital project, State of Syn, starring Jewel Staite and David Hewlett
March 28, 2012 9:30 AM

TORONTO/CANNES, March 28, 2012 /CNW/ - Shaftesbury and its award-winning digital media division, Smokebomb Entertainment, today announced casting and production details for State of Syn, a groundbreaking science fiction digital project. Starring Jewel Staite (Firefly, LA Complex), David Hewlett (Stargate SG-1, Stargate: Atlantis), and Rainbow Sun Francks (The Listener, Stargate: Atlantis), State of Syn (10 x five minutes) is a 3D-enabled digital motion novel for online, smartphone and tablet devices that combines live-action photography with animated hyper-real backgrounds.

. . . Featuring 10 five-minute narrative episodes, State of Syn takes place in a futuristic society where instability reigns but one commodity remains accessible to all: technology. The storyline follows Annika Drake (Staite) and her friends who, following the unexplained death of her father, are pulled into a twisted mystery surrounding his former company, emerging tech giant Psylosense. Now run by her father's former business partner Aslin Kane (Hewlett), Psylosense is manufacturing a highly addictive new sensory experience called Vibe - a digital technology simulating a neurological condition called synesthesia - which is poised to become the new opiate of the masses.